http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3218720-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2c666474ffc0184da7e8aafe5f0b324d
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-7028
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-52
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5743
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57484
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-04
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574
filingDate 2015-11-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_463dd9e7ea8e43ff257b0ee45fef9931
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f512aa8fc20f1affcb7b7b62cba803dd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_83b78b78eed7c520b64b5b3eae644abd
publicationDate 2017-09-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-3218720-A1
titleOfInvention Biomarkers for disease progression in melanoma
abstract The present invention relates inter alia to therapeutic agents for use in the treatment of melanoma, methods of diagnosing an increased risk of metastasis in a subject suffering from melanoma, methods of treating such subjects, diagnostic assays and kits. More particularly, in certain embodiments the invention relates to identifying whether a subject suffering from melanoma has an increased risk of metastasis by determining the expression of Ambra-1 and Loricrin in a tissue sample obtained from the subject.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021023962-A1
priorityDate 2014-11-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID13342
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID77473
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226397199
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406714
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226425023
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID41206
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11990
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5394
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399873
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID442514
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395766
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396483
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226421590
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID378
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226421591
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21292785
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406479
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6694
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226425024
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226421589
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2578
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID15764346
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226409349
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID171548
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID36314
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226400532
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395857
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5743464
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226421592
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4686862
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396057
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406715
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135398738

Total number of triples: 55.